XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income
Treasury Stock
Noncontrolling Interest
Beginning Balance at Dec. 31, 2020 $ 2,016,059 $ 2,710 $ 2,902,236 $ 472,014 $ 5,412 $ (1,366,313)  
Beginning Balance (in shares) at Dec. 31, 2020   271,029          
Net income (loss) (654,545)     (654,545)      
Foreign currency translation adjustment 503       503    
Release of cumulative translation adjustment 0            
Restricted stock issued for acquisition 248,025 $ 263 247,762        
Restricted stock issued for acquisition (in shares)   26,274          
Issuance of restricted stock   $ 6 (6)        
Issuance of restricted stock (in shares)   621          
Vesting of restricted stock units   $ 14 (14)        
Vesting of restricted stock units (in shares)   1,345          
Stock-based compensation 21,558   21,558        
Payment of cash dividends (15,605)     (15,605)      
Dividend equivalents (180)     (180)      
Purchase of treasury stock (6,328)         (6,328)  
Ending Balance at Dec. 31, 2021 1,609,487 $ 2,993 3,171,536 (198,316) 5,915 (1,372,641)  
Ending Balance (in shares) at Dec. 31, 2021   299,269          
Net income (loss) 154,658     154,658      
Foreign currency translation adjustment 1,793       1,793    
Release of cumulative translation adjustment (7,708)       (7,708)    
Issuance of restricted stock   $ 10 (10)        
Issuance of restricted stock (in shares)   980          
Vesting of restricted stock units   $ 14 (14)        
Vesting of restricted stock units (in shares)   1,437          
Exercise of stock options 10,368 $ 6 10,362        
Exercise of stock options (in shares)   640          
Stock-based compensation 21,099   21,099        
Payment of cash dividends (43,096)     (43,096)      
Dividend equivalents (640)     (640)      
Purchase of treasury stock (80,438)         (80,438)  
Ending Balance at Dec. 31, 2022 $ 1,665,523 $ 3,023 3,202,973 (87,394)   (1,453,079)  
Ending Balance (in shares) at Dec. 31, 2022 302,325,853 302,326          
Net income (loss) $ 245,952     246,292     $ (340)
Net income (loss) attribuable to noncontrolling interest 8,729           8,729
Foreign currency translation adjustment 472       472    
Issuance of common stock - Ulterra acquisition 521,406 $ 349 521,057        
Issuance of common stock - Ulterra acquisition, Share   34,900          
Issuance of common stock - NexTier merger 2,565,895 $ 1,720 2,564,175        
Issuance of common stock - NexTier merger, Share   172,092          
Issuance of replacement awards related to NexTier merger 72,413   72,413        
Release of cumulative translation adjustment $ 0            
Issuance of restricted stock   $ 10 (10)        
Issuance of restricted stock (in shares)   1,077          
Vesting of restricted stock units   $ 64 (64)        
Vesting of restricted stock units (in shares)   6,380          
Exercise of stock options (in shares) 0            
Stock-based compensation $ 46,750   46,750        
Payment of cash dividends (100,034)     (100,034)      
Dividend equivalents (1,829)     (1,829)      
Purchase of treasury stock (204,596)         (204,596)  
Ending Balance at Dec. 31, 2023 $ 4,820,681 $ 5,166 $ 6,407,294 $ 57,035 $ 472 $ (1,657,675) $ 8,389
Ending Balance (in shares) at Dec. 31, 2023 516,775,313 516,775